(Q34247377)

31 July 2017

1 reference

title

The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders (English)

1 reference

31 July 2017

Elliott S

1

1 reference

PubMed ID

11346130

31 July 2017

Cawston T

series ordinal

2

1 reference

31 July 2017

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

18

1 reference

31 July 2017

2

1 reference

31 July 2017

87-99

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200118020-00002

31 July 2017

0 references

cites work

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3

1 reference

12 December 2020

An aggrecan-degrading activity associated with chondrocyte membranes

1 reference

12 December 2020

Metalloproteinase inhibitors and the prevention of connective tissue breakdown

1 reference

12 December 2020

Biochemical characterization of human collagenase-3

1 reference

12 December 2020

Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation

1 reference

12 December 2020

Matrix metalloproteinases: a review

1 reference

12 December 2020

Characteristics of the action of human skin fibroblast collagenase on fibrillar collagen

1 reference

12 December 2020

Collagenase: a key enzyme in collagen turnover

1 reference

12 December 2020

The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations

1 reference

12 December 2020

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen

1 reference

12 December 2020

The capacity of pig articular cartilage in organ culture to regenerate after breakdown induced by complement-sufficient antiserum to pig erythrocytes

1 reference

12 December 2020

In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation

1 reference

12 December 2020

Joint destruction in arthritis: metalloproteinases in the spotlight

1 reference

12 December 2020

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

1 reference

12 December 2020

Proteinases and inhibitors

1 reference

12 December 2020

Matrix metalloproteinase inhibitors in arthritis

1 reference

12 December 2020

The breakdown of collagen by chondrocytes

1 reference

12 December 2020

Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity

1 reference

12 December 2020

The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study.

1 reference

12 December 2020

A matrix metalloproteinase expressed on the surface of invasive tumour cells

1 reference

12 December 2020

Prevention of cartilage breakdown by matrix metalloproteinase inhibition--a realistic therapeutic target?

1 reference

12 December 2020

Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M

1 reference

12 December 2020

The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules

1 reference

12 December 2020

Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage

1 reference

12 December 2020

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

1 reference

12 December 2020

Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine

1 reference

12 December 2020

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy

1 reference

12 December 2020

The collagen substrate specificity of human neutrophil collagenase

1 reference

12 December 2020

Collagen family of proteins

1 reference

12 December 2020

In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1.

1 reference

12 December 2020

Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family

1 reference

12 December 2020

Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis

1 reference

12 December 2020

Mighty mice: transgenic technology "knocks out" questions of matrix metalloproteinase function

1 reference

12 December 2020

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

12 December 2020

Tenidap reduces the level of interleukin 1 receptors and collagenase expression in human arthritic synovial fibroblasts

1 reference

12 December 2020

Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines

1 reference

12 December 2020

The matrix-degrading metalloproteinases

1 reference

12 December 2020

New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above

1 reference

12 December 2020

Wanted--the collagenase responsible for the destruction of the collagen network in human cartilage!

1 reference

12 December 2020

Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

1 reference

12 December 2020

Furin-dependent intracellular activation of the human stromelysin-3 zymogen

1 reference

12 December 2020

Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium

1 reference

12 December 2020

In vivo studies of articular tissue damage mediated by catabolin/interleukin 1.

1 reference

12 December 2020

Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2

1 reference

12 December 2020

Proteoglycans: many forms and many functions

1 reference

12 December 2020

The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages

1 reference

12 December 2020

Binding of gelatinases A and B to type-I collagen and other matrix components

1 reference

12 December 2020

10.2165/00002512-200118020-00002

Identifiers

DOI

1 reference

PubMed ID

11346130

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11346130